Technical innovations in peritoneal dialysis (PD), now used widely for the long-term
treatment of ESRD, have significantly reduced therapy-related complications, allowing …

Background Biocompatible peritoneal dialysis (PD) solutions, including neutral pH, low
glucose degradation product (GDP) solutions and icodextrin, have previously been shown to …

Blood pressure (BP) and volume control are critical components of dialysis care and have
substantial impacts on patient symptoms, quality of life, and cardiovascular complications …

Background Variability in ultrafiltration influences prescriptions and outcomes in patients
with kidney failure who are treated with peritoneal dialysis. Variants in AQP1, the gene that …

Lay summary Peritoneal dialysis (PD) uses the peritoneal membrane for dialysis. The
peritoneal membrane is a thin layer of tissue that lines the abdomen. The lining is used as a …

Nanoparticles (NPs) are novel drug delivery systems that have been attracting more and
more attention in recent years, and have been used for the treatment of cancer, infection …

Diabetic nephropathy is highly correlated with the occurrence of other complications of type
1 diabetes (T1D) and type 2 diabetes (T2D) mellitus; for example, hypertension with …

These guidelines cover all aspects of the care of patients who are treated with peritoneal
dialysis. This includes equipment and resources, preparation for peritoneal dialysis, and …

Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal
dialysis patients. Background Time on treatment is associated with a greater risk of impaired …

Results The study included 9362 patients from 51 centers in Australia. The technique failure
rate was 0.35 (95% confidence interval, 0.34 to 0.36) episodes per patient-year, with a …